{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:25:45Z","timestamp":1745497545924},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.thorsurg.2010.08.014","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T04:40:17Z","timestamp":1289364017000},"page":"33-46","source":"Crossref","is-referenced-by-count":6,"title":["Immunohistochemistry of Thymic Epithelial Tumors as a Tool in Translational Research"],"prefix":"10.1016","volume":"21","author":[{"given":"Mirella","family":"Marino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Piantelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2010.08.014_bib1","series-title":"Pathology & genetics. Tumours of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","article-title":"Thymic hyperplasia and neoplasia: a review of current concepts","volume":"9","author":"Levine","year":"1978","journal-title":"Hum Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00737071","article-title":"Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus","volume":"407","author":"Marino","year":"1985","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib6","first-page":"949","volume":"55","author":"Yamazaki","year":"2002","journal-title":"Kyobu Geka"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1010-7940(01)01091-0","article-title":"Prognostic factors in thymic epithelial neoplasms","volume":"21","author":"Rios","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib8","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","article-title":"Long-term outcome after multimodality treatment for stage III thymic tumors","volume":"76","author":"Venuta","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.athoracsur.2004.03.097","article-title":"Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification","volume":"78","author":"Park","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histologic classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib11","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Stroebel","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib12","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.athoracsur.2005.11.067","article-title":"Clinical value of the WHO classification system of thymoma","volume":"81","author":"Detterbeck","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1378\/chest.127.3.755","article-title":"Prognostic and clinical relevance of the world health organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review","volume":"127","author":"Kim","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1066896909334126","article-title":"The correlation of the World Health Organization histologic classification of thymic epithelial tumors and its prognosis: a clinicopathologic study of 108 patients from China","volume":"17","author":"Honglin","year":"2009","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11748-007-0177-8","article-title":"Clinical and pathological aspects of thymic epithelial tumors","volume":"56","author":"Okumura","year":"2008","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.athoracsur.2009.08.074","article-title":"Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery","volume":"89","author":"Margaritora","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejcts.2009.05.038","article-title":"Thymoma and thymic carcinoma","volume":"37","author":"Venuta","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2559.2008.03177.x","article-title":"Tumours and tumour-like conditions of the thymus other than thymoma; a practical approach","volume":"54","author":"den Bakker","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib19","first-page":"2","article-title":"Primary thymic epithelial neoplasms: spectrum of differentiation and histological features","volume":"16","author":"Suster","year":"1999","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib20","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/cncr.23492","article-title":"Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma","volume":"112","author":"Marchevsky","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2559.2008.03088.x","article-title":"Interobserver variation in the classification of thymic tumours\u2014a multicentre study using the WHO classification system","volume":"53","author":"Verghese","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcp\/111.6.826","article-title":"Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial\u00a0neoplasms","volume":"111","author":"Suster","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib23","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/PAS.0b013e31802b4917","article-title":"Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms","volume":"31","author":"Nonaka","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0463.2009.02437.x","article-title":"Differential expression of LAMPs and ubiquitin in human thymus","volume":"117","author":"Sarafian","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jso.21277","article-title":"L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas","volume":"99","author":"Kaira","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib26","first-page":"229","article-title":"Diagnostic and clinical significance of D2-40 expression in the normal human thymus and thymoma","volume":"51","author":"Raica","year":"2010","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2559.2002.01328.x","article-title":"Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms","volume":"40","author":"Pomplun","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2559.2002.01422.x","article-title":"Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma","volume":"41","author":"Attanoos","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.humpath.2003.07.002","article-title":"Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma","volume":"34","author":"Pan","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00707978","article-title":"Immunohistological evidences of cortical and medullary differentiation in thymoma","volume":"408","author":"Mueller-Hermelink","year":"1985","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000478-198601000-00004","article-title":"An immunohistochemical study of thymic epithelial tumors. I. Epithelial component","volume":"10","author":"Kodama","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2559.2000.00846.x","article-title":"Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas","volume":"36","author":"Kuo","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/00000478-199210000-00010","article-title":"Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen","volume":"16","author":"Chilosi","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib34","first-page":"268","article-title":"CD5 expression in thymic carcinoma","volume":"145","author":"Hishima","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00000478-199708000-00008","article-title":"Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity","volume":"21","author":"Dorfman","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcp\/109.6.722","article-title":"CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms","volume":"109","author":"Kornstein","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ajcp\/111.2.235","article-title":"Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma","volume":"111","author":"Tateyama","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Tyrosine kinase receptor expression in thymomas","volume":"130","author":"Henley","year":"2004","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00000478-199212000-00003","article-title":"Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma","volume":"16","author":"Kirchner","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00000478-199001000-00003","article-title":"Thymic carcinomas: histopathological varieties and immunohistochemical study","volume":"14","author":"Kuo","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00000478-199906000-00009","article-title":"Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm","volume":"23","author":"Suster","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.1808","article-title":"Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development","volume":"207","author":"Stroebel","year":"2005","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0344-0338(99)80005-3","article-title":"Low-grade metaplastic carcinomas of the thymus: biphasic thymic epithelial tumors with mesenchymal metaplasia\u2014an update","volume":"195","author":"Yoneda","year":"1999","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib46","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/PAS.0b013e3181a2443b","article-title":"Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma","volume":"33","author":"Brown","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00194697","article-title":"Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21","volume":"426","author":"Hayashi","year":"1995","journal-title":"Virchows Arch"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ajcp\/104.4.375","article-title":"p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study","volume":"104","author":"Tateyama","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<639::AID-IJC5>3.0.CO;2-Y","article-title":"p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma","volume":"73","author":"Hirabayashi","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib50","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/bjc.1997.561","article-title":"High frequency of p53 protein expression in thymic carcinoma but not in thymoma","volume":"76","author":"Hino","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s004280050064","article-title":"p53 alterations in thymic epithelial tumours","volume":"431","author":"Weirich","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib52","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/01.MP.0000038463.67854.84","article-title":"Proliferative activity and apoptosis in thymic epithelial neoplasms","volume":"15","author":"Hiroshima","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib53","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1158\/1078-0432.CCR-05-0070","article-title":"Analysis of cell cycle regulator proteins in encapsulated thymomas","volume":"11","author":"Baldi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jtcvs.2008.11.048","article-title":"Recurrent intrathoracic thymomas: potential prognostic importance of cell-cycle protein expression","volume":"138","author":"Mineo","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib55","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cncr.21433","article-title":"Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression","volume":"104","author":"Mineo","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1378\/chest.08-2482","article-title":"Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and nonreceptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms","volume":"136","author":"Khoury","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib57","first-page":"494","article-title":"p63 expression profiles in human normal and tumor tissues","volume":"8","author":"Di Como","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00428-003-0857-4","article-title":"Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours","volume":"443","author":"Chilosi","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib59","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/intimm\/dxh087","article-title":"Expression profiles and functional implications of p53-like transcription factors in thymic epithelial cell subtypes","volume":"16","author":"Kikuchi","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib60","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1309\/AJCPVTZ06DHKCOGP","article-title":"Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas","volume":"131","author":"Wu","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2559.1996.d01-540.x","article-title":"Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours","volume":"29","author":"Chen","year":"1996","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2559.2003.01663.x","article-title":"Expression of\u00a0apoptosis-related markers and HER-2\/neu in thymic epithelial tumours","volume":"43","author":"Pan","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib63","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1010-7940(01)00776-X","article-title":"The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters","volume":"20","author":"Salakou","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.1993.tb01181.x","article-title":"Expression of epidermal and nerve growth factor receptors in human thymus and thymomas","volume":"23","author":"Pescarmona","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib65","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cncr.20811","article-title":"Protein expression and gene amplification of epidermal growth factor receptor in thymomas","volume":"103","author":"Ionescu","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jcp.48.5.447","article-title":"Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen","volume":"48","author":"Gilhus","year":"1995","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jjco\/hyl028","article-title":"Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors","volume":"36","author":"Suzuki","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib68","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","article-title":"Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas","volume":"248","author":"Meister","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib70","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Stroebel","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.lungcan.2008.03.013","article-title":"Mutational status of EGFR and KIT in thymoma and thymic carcinoma","volume":"62","author":"Yoh","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib73","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mtc.2002.124389","article-title":"Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors","volume":"124","author":"Tomita","year":"2002","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.aanat.2007.05.003","article-title":"Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus","volume":"190","author":"Cimpean","year":"2008","journal-title":"Ann Anat"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib76","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.19087","article-title":"A\u00a0phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma [abstract 19087]. ASCO Annual Meeting Proceedings","volume":"26","author":"Bedano","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib77","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ijc.22078","article-title":"COX-2 upregulation in thymomas and thymic carcinomas","volume":"119","author":"Rieker","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib78","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/1521-4141(200205)32:5<1482::AID-IMMU1482>3.0.CO;2-O","article-title":"Distinct expression of cyclooxygenase-1 and -2 in the human thymus","volume":"32","author":"Rocca","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/hmg\/10.7.657","article-title":"Tissue microarray technology for high-throughput molecular profiling of cancer","volume":"10","author":"Kallioniemi","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1309\/2GAYKPDDM85P2VEW","article-title":"Expression of p63 in thymomas and normal thymus","volume":"127","author":"Dotto","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A\u00a0quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib82","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s005950170021","article-title":"Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surg Today"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone","volume":"336","author":"Palmieri","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib84","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/cncr.10374","article-title":"Somatostatin analogs and prednisone in advanced refractory thymic tumors","volume":"94","author":"Palmieri","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib85","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF03343886","article-title":"In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features","volume":"24","author":"Ferone","year":"2001","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib86","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.2741\/3453","article-title":"Somatostatin receptor expression in thymic tumors","volume":"14","author":"Ferone","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib87","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3816\/CLC.2004.n.018","article-title":"Thymoma and thymic carcinoma: therapeutic approaches","volume":"6","author":"Kurup","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib89","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1200\/JCO.2006.08.8963","article-title":"Dasatinib induces a response in malignant thymoma","volume":"24","author":"Chuah","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib90","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","article-title":"Cetuximab is an active treatment of metastatic and chemorefractory thymoma","volume":"12","author":"Palmieri","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib91","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","article-title":"Response of thymoma to cetuximab","volume":"8","author":"Farina","year":"2007","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.thorsurg.2010.08.014_bib92","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/annonc\/mdn388","article-title":"Response of malignant thymoma to erlotinib","volume":"19","author":"Christodoulou","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib93","doi-asserted-by":"crossref","first-page":"16s","DOI":"10.1200\/jco.2005.23.16_suppl.7068","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2010.08.014_bib94","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/ijc.23335","article-title":"Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma","volume":"122","author":"Ehemann","year":"2008","journal-title":"Int J Cancer"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412710001416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412710001416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T18:57:43Z","timestamp":1544122663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412710001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1547412710001416"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2010.08.014","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}